Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients

被引:3
|
作者
Xing, Zheyu [1 ,2 ,3 ,4 ]
Wang, Yaqin [1 ,2 ,3 ,4 ]
Gong, Kunjing [1 ,2 ,3 ,4 ]
Chen, Yuqing [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ First Hosp, Div Renal, Beijing, Peoples R China
[2] Peking Univ, Inst Nephrol, Beijing, Peoples R China
[3] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China
[4] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Hemodialysis; Complement factor 4; Complement activation; Cardiovascular and cerebrovascular diseases; Prognosis; All-cause mortality; MANNOSE-BINDING LECTIN; COMPLEMENT ACTIVATION; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PLATELET COUNT; SERUM-ALBUMIN; DISEASE; RISK; INFLAMMATION; PREDICTORS;
D O I
10.1186/s12882-022-02829-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Patients on maintenance hemodialysis (HD) exhibit a high risk of death, cardiovascular and cerebrovascular diseases (CCDs). Previous studies indicated complement activation associated with the increased risk of cardiovascular diseases in HD patients. This study aimed to explore whether the critical complement factors were associated with the adverse outcomes in HD patients. Methods A total of 108 HD patients were included and followed up for 52 months. The baseline clinical characteristics and plasma C3c, C1q, CFH, CFB, C4, MAC, C5a, C3a and MBL were measured. The three endpoints were death, cardiovascular and cerebrovascular events (CCEs) and the composition of them. Univariate and multivariate Cox regression identified factors associated with the three endpoints respectively. X-tile analyses determined the optimal cut-off values for high risks. Restricted cubic spline plots illustrated the dose-response relationships. Correlations between the complement factors and risk factors for CCDs were analyzed. Results Baseline plasma C4 was finally selected by univariate and multivariate Cox regression analyses for three endpoints, including all-cause mortality, CCEs and the composition of them. When baseline plasma C4 exceeded 0.47 (P = 0.001) or 0.44 (P = 0.018) g/L respectively, the risks for death or achieving the composite endpoint enhanced significantly. The relationships of C4 and HR for the three endpoints showed a positive linear trend. Plasma C4 had prominent correlations with blood TG (r = 0.62, P < 0.001) and HDL (r = -0.38, P < 0.001). Conclusions A higher baseline plasma C4 level was significantly associated with the future incidence of decease, CCEs and either of them. Plasma C4 level correlated with blood TG and HDL.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients
    Zheyu Xing
    Yaqin Wang
    Kunjing Gong
    Yuqing Chen
    BMC Nephrology, 23
  • [2] PROGNOSTIC VALUE OF PLASMA C4 LEVEL FOR FUTURE MORTALITY, CARDIOVASCULAR AND CEREBROVASCULAR COMPLICATIONS IN HAEMODIALYSIS PATIENTS
    Xing, Zheyu
    Wang, Yaqin
    Gong, Kunjing
    Chen, Yuqing
    NEPHROLOGY, 2021, 26 : 48 - 48
  • [3] Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients
    Deicher, R
    Ziai, F
    Bieglmayer, C
    Schillinger, M
    Hörl, WH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06): : 1811 - 1818
  • [4] Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
    Matsumoto, Yoshihiro
    Mori, Yasuo
    Kageyama, Shinji
    Arihara, Kazuo
    Sugiyama, Toshikazu
    Ohmura, Hiromichi
    Yakushigawa, Toru
    Sugiyama, Hatsumi
    Shimada, Yasushi
    Nojima, Youichi
    Shio, Nobuo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 529 - 536
  • [5] Low Vitamin E Plasma Levels Are Associated with Cerebrovascular Events and Mortality in Hemodialysis Patients
    Espe, K. M.
    Raila, J.
    Henze, A.
    Blouin, K.
    Schneider, A.
    Schmiedeke, D.
    Krane, V.
    Schweigert, E. J.
    Hocher, B.
    Wanner, C.
    Drechsler, C.
    ANNALS OF NUTRITION AND METABOLISM, 2012, 60 (02) : 137 - 137
  • [6] Lower serum irisin levels are associated with the increasing mortality of cardiovascular and cerebrovascular diseases in hemodialysis patients
    Dong, Xingtong
    Fu, Wenjing
    Deng, Yinghui
    Jia, Linpei
    Lin, Na
    Li, Wen
    Zhang, Aihua
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (06) : 6052 - 6061
  • [7] Frailty Associated with Cardiovascular Mortality in Hemodialysis Patients
    Chen, Chiu-Hui
    Yeh, Tzu-Shan
    Dai, Li-Pei
    Luo, Chien-Ming
    Yang, Chung-Wei
    Wu, Chih-Cheng
    ACTA CARDIOLOGICA SINICA, 2025, 41 (02) : 219 - 229
  • [8] Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients
    Huang, Chi-Lun
    Jong, Yuh-Shiun
    Wu, Yen-Wen
    Wang, Wei-Jie
    Hsieh, Ai-Ru
    Chao, Chia-Lun
    Chen, Wen-Jone
    Yang, Wei-Shiung
    ACTA CARDIOLOGICA SINICA, 2015, 31 (02) : 113 - 119
  • [9] Hematocrit level and associated mortality in hemodialysis patients
    Ma, JZ
    Ebben, J
    Xia, H
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (03): : 610 - 619
  • [10] Plasma osteoprotegerin is associated with mortality in hemodialysis patients
    Morena, Marion
    Terrier, Nathalie
    Jaussent, Isabelle
    Leray-Moragues, Helene
    Chalabi, Lotfi
    Rivory, Jean-Pierre
    Maurice, Francois
    Delcourt, Cecile
    Cristol, Jean-Paul
    Canaud, Bernard
    Dupuy, Anne-Marie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (01): : 262 - 270